Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 20, Issue 6, 2014, Pages 644-646

  Moonen, A J H ^a   Wijers, A ^a   Leentjens, A F G ^a   Christine, C W ^b   Factor, S A ^c   Juncos, J ^c   Lyness, J M ^m   Marsh, L ^d,e   Panisset, M ^f   Pfeiffer, R ^g   Rottenberg, D ^h   Serrano Ramos, C ⁱ   Shulman, L ^j   Singer, C ^k   Slevin, J ^l   McDonald, W ^c   Auinger, P ^m   Richard, I H ^m  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

^g UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^h UNIVERSITY OF MINNESOTA   (United States)

ⁱ UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^j UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF KENTUCKY   (United States)

^m UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

more..

Author keywords

Clinical trials randomized controlled; Depression; Parkinson's disease; Paroxetine; Venlafaxine

Indexed keywords

ANTIDEPRESSANT AGENT; PAROXETINE; PLACEBO; VENLAFAXINE; CYCLOHEXANOL DERIVATIVE;

ADULT; AGE; ANXIETY; ARTICLE; DEPRESSION; DISEASE SEVERITY; FEMALE; GENDER; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PARKINSON DISEASE; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT RESPONSE; UNIFIED PARKINSON DISEASE RATING SCALE; AGED; COMPLICATION; DOUBLE BLIND PROCEDURE; DRUG THERAPY; FOLLOW UP; INFORMATION PROCESSING; MIDDLE AGED; PREDICTIVE VALUE; SEVERITY OF ILLNESS INDEX;

AGED; ANTIDEPRESSIVE AGENTS; ANXIETY; CYCLOHEXANOLS; DATASETS AS TOPIC; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PAROXETINE; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX;

EID: 84900012852     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.02.025     Document Type: Article

References (10)

1. Reijnders J.S.A.M., Ehrt U., Weber W.E.J., Aarsland D., Leentjens A.F.G. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 2008, 23(2):183-189.
2. Richard I.H., McDermott M., Kurlan R., Lyness J., Como P., Pearson N., et al. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology 2012, 78(16):1129-1136.
3. Khan A., Leventhal R.M., Khan S.R., Brown W.A. Severity of depression and response to antidepressants and placebo: an analysis of the food and drug administration database. J Clin Psychopharmacol 2001, 22(1):40-45.
4. Santangelo G., Vitale C., Trojano L., Longo K., Cozzolino A., Grossi D., et al. Relationship between depression and cognitive dysfunctions in Parkinson's disease without dementia. J Neurol 2009, 256(4):632-638.
5. Weintraub D., Moberg P.J., Duda J.E., Katz I.R., Stern M.B. Recognition and treatment of depression in Parkinson's disease. J Geriatr Psychiatry Neurol 2003, 16(3):178-183.
6. Ising M., Lucae S., Binder E., Bettecken T., Uhr M., Ripke S., et al. A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Arch Gen Psychiatry 2009, 66(9):966-975.
7. Cohen A., Gilman S.E., Houck P.R., Szanto K., Reynolds C.F. Socioeconomic status and anxiety as predictors of antidepressant treatment response and suicidal ideation in older adults. Soc Psychiatry Psychiatr Epidemiol 2009, 44:272-277.
8. Nelson J.C., Zhang Q., Deberdt W., Marangell L.B., Karamustafalioglu O., Lipkovich I.A. Predictors of remission with placebo using an integrated study database from patients with major depressive disorder. Curr Med Res Opin 2012, 28:325-334.
9. Tobler P.N., Fiorillo C.D., Schultz W. Adaptive coding of reward value by dopamine neurons. Science 2005, 307(5715):1642-1645.
10. Hennings J.M., Owashi T., Binder E.B., Horstmann S., Menke A., Kloiber S., et al. Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project. J Psychiatr Res 2008, 43:215-229.